Profits and LossesThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. Subscribe to this data using MyMedWorm.Subscribe to this data using GoogleReader.Subscribe to this data using Bloglines.Subscribe to this data using MyYahoo.

This page shows you your search results in order of date.

Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30

2689 records returned

Omeros loses $3.9M in Q3Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Omeros Corp., a biopharmaceutical company that went public last month, reported a third-quarter loss of $3.9 million, or a loss of $1.34 per share. (OMER) (Source: bizjournals.com Health Care:Health Insurance headlines)
Source: bizjournals.com Health Care:Health Insurance headlines - November 19, 2009 Category: American Health Source Type: journals

Omeros loses $3.9M in Q3Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Omeros Corp., a biopharmaceutical company that went public last month, reported a third-quarter loss of $3.9 million, or a loss of $1.34 per share. (OMER) (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 19, 2009 Category: Biotechnology Source Type: journals

OncoVista posts third-quarter loss despite revenue growthEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
OncoVista Innovative Therapies Inc. is continuing to build its revenues as the development stage company works toward becoming profitable. (Source: bizjournals.com Health Care:Health Insurance headlines)
Source: bizjournals.com Health Care:Health Insurance headlines - November 19, 2009 Category: American Health Source Type: journals

OncoVista posts third-quarter loss despite revenue growthEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
OncoVista Innovative Therapies Inc. is continuing to build its revenues as the development stage company works toward becoming profitable. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 19, 2009 Category: Biotechnology Source Type: journals

Covidien charges sink Q4 profitEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Global healthcare products company Covidien took charges in its fiscal 2009 fourth quarter, which ended Sept. 30, that saw profits slide 86 percent compared with the same period last year. (Source: Health Imaging News)
Source: Health Imaging News - November 19, 2009 Category: Radiology Tags: Latest News Source Type: news

Mount Sinai Medical Center turns profitEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Mount Sinai Medical Center posted a huge financial turnaround in the third quarter that put it on pace for its most profitable year this decade. (Source: bizjournals.com Health Care:Health Insurance headlines)
Source: bizjournals.com Health Care:Health Insurance headlines - November 18, 2009 Category: American Health Source Type: journals

Mount Sinai Medical Center turns profitEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Mount Sinai Medical Center posted a huge financial turnaround in the third quarter that put it on pace for its most profitable year this decade. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 18, 2009 Category: Biotechnology Source Type: journals

Ophthalmic swings to a Q3 profitEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Ophthalmic Imaging Systems Inc. reported net income of $86,000 for the quarter ended Sept. 30, up from a net loss of $416,000 for the same period a year ago. (Source: bizjournals.com Health Care:Health Insurance headlines)
Source: bizjournals.com Health Care:Health Insurance headlines - November 17, 2009 Category: American Health Source Type: journals

Ophthalmic swings to a Q3 profitEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Ophthalmic Imaging Systems Inc. reported net income of $86,000 for the quarter ended Sept. 30, up from a net loss of $416,000 for the same period a year ago. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 17, 2009 Category: Biotechnology Source Type: journals

IsoRay shows Q1 slumpEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Medical isotope developer IsoRay showed a downturn in sales and profit for the Richland, Wash.-based firm's fiscal 2010 first quarter, which ended Sept. 30. (Source: Health Imaging News)
Source: Health Imaging News - November 17, 2009 Category: Radiology Tags: Latest News Source Type: news

Covidien profit plunges, raises outlookEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Covidien said Tuesday that its fourth-quarter profit dropped to one-seventh of what it was a year ago due to charges related to divestitures and acquisitions, but also said it raised its sales-growth projection. (COV) (Source: bizjournals.com Health Care:Health Insurance headlines)
Source: bizjournals.com Health Care:Health Insurance headlines - November 17, 2009 Category: American Health Source Type: journals

Covidien profit plunges, raises outlookEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Covidien said Tuesday that its fourth-quarter profit dropped to one-seventh of what it was a year ago due to charges related to divestitures and acquisitions, but also said it raised its sales-growth projection. (COV) (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 17, 2009 Category: Biotechnology Source Type: journals

Scientific Industries Reports Results for QuarterEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
BOHEMIA, N.Y., Nov. 17, 2009 (GLOBE NEWSWIRE) -- Scientific Industries Inc. (OTCBB:SCND) reported yesterday improved operating results for the first quarter of the current fiscal year compared with the first quarter of the prior fiscal year -- Net income of $43,500 ($.04 per basic share) for the three months ended September 30, 2009 vs. a net loss of ($78,100) ($.07 per basic share) for the three months ended September 30, 2008. The improvement was mainly the result of an increase of $271,700 (28%) in net sales to $1,244,000. (Source: Medical News (via PRIMEZONE))
Source: Medical News (via PRIMEZONE) - November 17, 2009 Category: Pharmaceuticals Source Type: news

HMSA reports $32M loss in Q3Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The Hawaii Medical Service Association lost $32 million in the third quarter — a result of continued hits from rising health-care costs and declining investment income. (Source: bizjournals.com Health Care:Health Insurance headlines)
Source: bizjournals.com Health Care:Health Insurance headlines - November 17, 2009 Category: American Health Source Type: journals

HMSA reports $32M loss in Q3Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The Hawaii Medical Service Association lost $32 million in the third quarter — a result of continued hits from rising health-care costs and declining investment income. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 17, 2009 Category: Biotechnology Source Type: journals

HMSA reports $23M loss in Q3Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The Hawaii Medical Service Association lost $23 million in the third quarter — a result of continued hits from rising health-care costs and declining investment income. (Source: bizjournals.com Health Care:Health Insurance headlines)
Source: bizjournals.com Health Care:Health Insurance headlines - November 17, 2009 Category: American Health Source Type: journals

HMSA reports $23M loss in Q3Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
The Hawaii Medical Service Association lost $23 million in the third quarter — a result of continued hits from rising health-care costs and declining investment income. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 17, 2009 Category: Biotechnology Source Type: journals

Kaiser Hawaii reports $1M loss in Q3Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Kaiser Permanente Hawaii on Tuesday reported a $1 million loss in the third quarter of 2009, compared to a $2.9 million loss during the same period last year. (Source: bizjournals.com Health Care:Health Insurance headlines)
Source: bizjournals.com Health Care:Health Insurance headlines - November 17, 2009 Category: American Health Source Type: journals

Kaiser Hawaii reports $1M loss in Q3Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Kaiser Permanente Hawaii on Tuesday reported a $1 million loss in the third quarter of 2009, compared to a $2.9 million loss during the same period last year. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 17, 2009 Category: Biotechnology Source Type: journals

Kaiser Hawaii posts $1M loss in Q3Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Kaiser Permanente Hawaii on Tuesday reported a $1 million loss in the third quarter of 2009, compared to a $2.9 million loss during the same period last year. (Source: bizjournals.com Health Care:Health Insurance headlines)
Source: bizjournals.com Health Care:Health Insurance headlines - November 17, 2009 Category: American Health Source Type: journals

Kaiser Hawaii posts $1M loss in Q3Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Kaiser Permanente Hawaii on Tuesday reported a $1 million loss in the third quarter of 2009, compared to a $2.9 million loss during the same period last year. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 17, 2009 Category: Biotechnology Source Type: journals

Targeted Genetics reports $671K net income in Q3Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Targeted Genetics Corp. reported third-quarter net income rose to $671,000, or 3 cents per share, compared with a loss of $2.7 million, or a loss of 13 cents per share a year earlier. (TGEN) (Source: bizjournals.com Health Care:Health Insurance headlines)
Source: bizjournals.com Health Care:Health Insurance headlines - November 16, 2009 Category: American Health Source Type: journals

Targeted Genetics reports $671K net income in Q3Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Targeted Genetics Corp. reported third-quarter net income rose to $671,000, or 3 cents per share, compared with a loss of $2.7 million, or a loss of 13 cents per share a year earlier. (TGEN) (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 16, 2009 Category: Biotechnology Source Type: journals

New acute and chronic black holes in patients with multiple sclerosis randomised to interferon beta-1b or glatiramer acetateEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Background: Hypointense lesions on T1 weighted MRI, referred to as black holes (BH), are a marker of demyelination/axonal loss in multiple sclerosis (MS). There is some evidence that glatiramer acetate (GA) may decrease the conversion of new brain lesions to BH. Methods: Monthly 3-Tesla brain MRI scans were used for up to 2 years to study the development and evolution of new BH in 75 patients with MS randomised to GA or Interferon β-1b (IFNβ1b) in the BECOME study. Findings: Of 1224 newly enhancing lesions (NEL) appearing at baseline through 24 months in 61 patients, 767 (62.7%) showed an acute BH (ABH). The ma...
Source: Journal of Neurology, Neurosurgery & Psychiatry - November 16, 2009 Category: Neurosurgery Authors: Cadavid, D, Cheriyan, J, Skurnick, J, Lincoln, J A, Wolansky, L J, Cook, S D Tags: Immunology (including allergy), Multiple sclerosis, Neuroimaging, Radiology, Radiology (diagnostics) Research papers Source Type: journals

Sunesis reports $4.9M lossEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Sunesis Pharmaceuticals Inc. lost $4.9 million in the September quarter. (SNSS) (Source: bizjournals.com Health Care:Health Insurance headlines)
Source: bizjournals.com Health Care:Health Insurance headlines - November 16, 2009 Category: American Health Source Type: journals

Sunesis reports $4.9M lossEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Sunesis Pharmaceuticals Inc. lost $4.9 million in the September quarter. (SNSS) (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 16, 2009 Category: Biotechnology Source Type: journals

Bioheart narrows losses, raises $3.9MEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Bioheart narrowed its losses in the third quarter, and then completed a nearly $3.9 million private stock offering. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - November 16, 2009 Category: Pharmaceuticals Source Type: journals

Bioheart narrows losses, raises $3.9MEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Bioheart narrowed its losses in the third quarter, and then completed a nearly $3.9 million private stock offering. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 16, 2009 Category: Biotechnology Source Type: journals

Health reform on investors' minds as insurers report earningsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Even health plans that reported third-quarter profits are wary about a future that might include tighter regulation and cuts in profitable Medicare Advantage plans. (Source: American Medical News - BUSINESS)
Source: American Medical News - BUSINESS - November 16, 2009 Category: American Health Source Type: news

The Namibian conservation safari that keeps both animals and tourists happyEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Sleeping under the stars, meeting villagers and monitoring wildlife on foot ... this Namibian conservation project gives a glimpse of an Africa rarely seen on safariAfter dark we sit around the campfire listening to the sounds of the Namibian bush. An owl calls, then comes the pulsating thrum of a nightjar, plus all the insects and the unidentifiable rustlings of the leaf litter. In this dry season the mopane trees are almost leafless, but occasional flashes of lightning promise rain. Our guides, François de Wet and Neil Bone, are reminiscing about bush camps and the time their friend Dave got dragged away inside his slee...
Source: Guardian Unlimited Science - November 14, 2009 Category: Science Authors: Kevin Rushby Tags: Namibia Safaris Africa Green travel Animal behaviour Animal research Animal welfare The Guardian Features Source Type: news

Trimeris profit sliced in halfEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
A drop in sales and an increase in taxes drove down Trimeris Inc.’s quarterly net income by nearly $2 million, the Morrisville-based company said after markets closed Thursday. (Source: bizjournals.com Health Care:Health Insurance headlines)
Source: bizjournals.com Health Care:Health Insurance headlines - November 13, 2009 Category: American Health Source Type: journals

Trimeris profit sliced in halfEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
A drop in sales and an increase in taxes drove down Trimeris Inc.’s quarterly net income by nearly $2 million, the Morrisville-based company said after markets closed Thursday. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 13, 2009 Category: Biotechnology Source Type: journals

MDRNA cuts Q3 loss; gets NASDAQ warningEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
MDRNA Inc. reported a third-quarter loss of $7 million, or a loss of 17 cents per share, which compares with a loss of $16 million, or a loss of 52 cents a year earlier. (MRNA) (Source: bizjournals.com Health Care:Health Insurance headlines)
Source: bizjournals.com Health Care:Health Insurance headlines - November 13, 2009 Category: American Health Source Type: journals

MDRNA cuts Q3 loss; gets NASDAQ warningEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
MDRNA Inc. reported a third-quarter loss of $7 million, or a loss of 17 cents per share, which compares with a loss of $16 million, or a loss of 52 cents a year earlier. (MRNA) (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 13, 2009 Category: Biotechnology Source Type: journals

Bio Medica sales, earnings down in 3rd-QEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Kinderhook, N.Y., company American Bio Medica Corp., which makes drug testing kits, reported declining third-quarter revenue and profit on Thursday. (Source: bizjournals.com Health Care:Health Insurance headlines)
Source: bizjournals.com Health Care:Health Insurance headlines - November 13, 2009 Category: American Health Source Type: journals

Bio Medica sales, earnings down in 3rd-QEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Kinderhook, N.Y., company American Bio Medica Corp., which makes drug testing kits, reported declining third-quarter revenue and profit on Thursday. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 13, 2009 Category: Biotechnology Source Type: journals

Vision-Sciences, Inc. Announces $6.2 Million in Revenue for the First Half of Fiscal 2010Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
ORANGEBURG, N.Y., Nov. 12, 2009 (GLOBE NEWSWIRE) -- Vision-Sciences, Inc., (Nasdaq:VSCI) today announced results for its second quarter and first half of fiscal 2010, ended September 30, 2009. For the second quarter of fiscal 2010, revenues were $2.9 million, an increase of $0.1 million, or 4%, over the second quarter of fiscal 2009, ended September 30, 2008. For the first half of fiscal 2010, revenues were $6.2 million, an increase of $0.7 million, or 13%, over the first half of fiscal 2009. Loss from operations in the second quarter of fiscal 2010 was $3.1 million compared to $3.7 million in the second quarter of fiscal ...
Source: Medical News (via PRIMEZONE) - November 12, 2009 Category: Pharmaceuticals Source Type: news

Transcept Pharmaceuticals reports $3.8M loss in Q3Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Transcept Pharmaceuticals Inc. lost $3.8 million in the September quarter. (TSPT) (Source: bizjournals.com Health Care:Health Insurance headlines)
Source: bizjournals.com Health Care:Health Insurance headlines - November 12, 2009 Category: American Health Source Type: journals

Transcept Pharmaceuticals reports $3.8M loss in Q3Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Transcept Pharmaceuticals Inc. lost $3.8 million in the September quarter. (TSPT) (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 12, 2009 Category: Biotechnology Source Type: journals

Iridex Corp. swings to Q3 profitEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Medical laser company Iridex Corp. earned $646,000 in the third quarter ended Oct. 3. (IRIX) (Source: bizjournals.com Health Care:Health Insurance headlines)
Source: bizjournals.com Health Care:Health Insurance headlines - November 12, 2009 Category: American Health Source Type: journals

Iridex Corp. swings to Q3 profitEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Medical laser company Iridex Corp. earned $646,000 in the third quarter ended Oct. 3. (IRIX) (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 12, 2009 Category: Biotechnology Source Type: journals

Catalyst Pharmaceutical narrows lossesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Catalyst Pharmaceutical Partners narrowed its losses to $1.3 million, or 9 cents a share, in the third quarter, from a loss of $2.9 million, or 22 cents a share, in the same quarter last year. (CPRX) (Source: bizjournals.com Health Care:Health Insurance headlines)
Source: bizjournals.com Health Care:Health Insurance headlines - November 12, 2009 Category: American Health Source Type: journals

Catalyst Pharmaceutical narrows lossesEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Catalyst Pharmaceutical Partners narrowed its losses to $1.3 million, or 9 cents a share, in the third quarter, from a loss of $2.9 million, or 22 cents a share, in the same quarter last year. (CPRX) (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 12, 2009 Category: Biotechnology Source Type: journals

People entering their 60s may have more disabilities today than in prior generationsEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
In a development that could have significant ramifications for the nation's health care system, Baby Boomers may well be entering their 60s suffering far more disabilities than their counterparts did in previous generations, according to a new UCLA study. The findings, researchers say, may be due in part to changing American demographics. In the study, which will be published in the January 2010 issue of the American Journal of Public Health, researchers from the division of geriatrics at the David Geffen School of Medicine at UCLA found that the cohort of individuals b...
Source: UCLA Newsroom: Health Sciences - November 12, 2009 Category: Universities & Medical Training Source Type: organizations

Mindray's net income booms in Q3Email this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Mindray Medical, a Shenzhen, China-based medical device manufacturer, has reported an increase in profits of 55.2 percent in its fiscal 2009 third quarter, ending Sept. 30. (Source: Health Imaging News)
Source: Health Imaging News - November 12, 2009 Category: Radiology Tags: Latest News Source Type: news

Aryx Therapeutics reports $8.2M lossEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Aryx Therapeutics Inc. lost $8.2 million in the third quarter ended September. A year earlier in the same quarter, Aryx earned $3.2 million. (ARYX) (Source: bizjournals.com Health Care:Health Insurance headlines)
Source: bizjournals.com Health Care:Health Insurance headlines - November 12, 2009 Category: American Health Source Type: journals

Aryx Therapeutics reports $8.2M lossEmail this article to a colleague. Save this article to My Clippings. Discuss or comment on this article.
Aryx Therapeutics Inc. lost $8.2 million in the third quarter ended September. A year earlier in the same quarter, Aryx earned $3.2 million. (ARYX) (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - November 12, 2009 Category: Biotechnology Source Type: journals